摘要
目的 :观察欣母沛在预防和减少剖宫产术后出血的疗效。方法 :选择有产科剖宫产指征 ,并存在产后出血倾向因素者 14 2例 ,随机分为欣母沛组、催产素组 ,前者在胎儿娩出后立即宫体注射欣母沛、后者注射催产素 ,比较两组术中及产后 2 4小时内的出血情况。结果 :欣母沛组产后出血发生率明显少于催产素组 ,产后 2小时、2 4小时平均出血量也明显减少。结论 :欣母沛用于预防有产后出血倾向的剖宫产患者 ,具有明显的疗效 ,并具有方便、快速。
Objective: To assess effect of hemabate in reduction and prevention of hemorrhage after cesarean section(CS). Methods: According to either use of hemostatic agents or oxytocin after CS, 142 patients who had CS indications were assigned randomly to two groups:hemabate group (73 cases) and oxytocin group(69 cases). The women in two groups were injected hemabate and oxytocin into their uterine corpus immediately after CS, respectively.The total bleeding amounts of women who underwent CS in two groups during operation and within 24 hours after operation were compared. Results: The bleeding amounts at two hours and 24 hours after delivery in hemabate group were both much less than those in oxytocin group. Conclusion:Hemabate is convenient, safe, effective and less expensive in reduction and prevention of CS postoperative hemorrhage.
出处
《国外医学（妇幼保健分册）》
2004年第2期122-123,共2页
Foreign Medical Sciences (Section of Maternal and Child Health)
关键词
产后出血倾向
剖宫产
欣母沛
postpartum hemorrhage
cesarean section
hemabate
